This is the authors' abstract. We don't add key points for this paper.
Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a series of propeller shaped PI3Kδ inhibitors comprising a novel triaminopyrimidine hinge binder. Combinations of electronic and structural strategies were employed to mitigate aldehyde oxidase mediated metabolism. This medicinal chemistry effort culminated in the identification of 52, a potent and highly selective inhibitor of PI3Kδ that demonstrates efficacy in a rat model of arthritis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: